Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Short term Debt (2016 - 2023)

Historic Short term Debt for Creative Medical Technology Holdings (CELZ) over the last 15 years, with Q1 2023 value amounting to $14194.0.

  • Creative Medical Technology Holdings' Short term Debt changed 0.0% to $14194.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $14194.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $14194.0 for FY2022, which is 0.0% changed from last year.
  • Creative Medical Technology Holdings' Short term Debt amounted to $14194.0 in Q1 2023, which was down 0.0% from $14194.0 recorded in Q4 2022.
  • Over the past 5 years, Creative Medical Technology Holdings' Short term Debt peaked at $38.7 million during Q4 2020, and registered a low of $14194.0 during Q4 2021.
  • Moreover, its 5-year median value for Short term Debt was $1.4 million (2019), whereas its average is $3.6 million.
  • As far as peak fluctuations go, Creative Medical Technology Holdings' Short term Debt soared by 46574.95% in 2020, and later tumbled by 9996.34% in 2021.
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' Short term Debt stood at $6.8 million in 2019, then skyrocketed by 465.75% to $38.7 million in 2020, then crashed by 99.96% to $14194.0 in 2021, then changed by 0.0% to $14194.0 in 2022, then changed by 0.0% to $14194.0 in 2023.
  • Its Short term Debt was $14194.0 in Q1 2023, compared to $14194.0 in Q4 2022 and $14194.0 in Q3 2022.